Coronavirus biology and replication: implications for SARS-CoV-2
Philip V’kovski
1, 2
,
Annika Kratzel
1, 2, 3
,
Silvio Steiner
1, 2, 3
,
Hanspeter Stalder
1, 2
,
V. Thiel
1, 2
1
Institute of Virology and Immunology (IVI), Bern, Switzerland
|
Publication type: Journal Article
Publication date: 2020-10-28
scimago Q1
wos Q1
SJR: 13.861
CiteScore: 106.4
Impact factor: 103.3
ISSN: 17401526, 17401534
PubMed ID:
33116300
Microbiology
Infectious Diseases
General Immunology and Microbiology
Abstract
The SARS-CoV-2 pandemic and its unprecedented global societal and economic disruptive impact has marked the third zoonotic introduction of a highly pathogenic coronavirus into the human population. Although the previous coronavirus SARS-CoV and MERS-CoV epidemics raised awareness of the need for clinically available therapeutic or preventive interventions, to date, no treatments with proven efficacy are available. The development of effective intervention strategies relies on the knowledge of molecular and cellular mechanisms of coronavirus infections, which highlights the significance of studying virus–host interactions at the molecular level to identify targets for antiviral intervention and to elucidate critical viral and host determinants that are decisive for the development of severe disease. In this Review, we summarize the first discoveries that shape our current understanding of SARS-CoV-2 infection throughout the intracellular viral life cycle and relate that to our knowledge of coronavirus biology. The elucidation of similarities and differences between SARS-CoV-2 and other coronaviruses will support future preparedness and strategies to combat coronavirus infections. In this Review, Thiel and colleagues discuss the key aspects of coronavirus biology and their implications for SARS-CoV-2 infections as well as for treatment and prevention strategies.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
10
20
30
40
50
60
70
80
90
100
|
|
|
Viruses
91 publications, 3.48%
|
|
|
International Journal of Molecular Sciences
70 publications, 2.68%
|
|
|
bioRxiv
67 publications, 2.56%
|
|
|
Frontiers in Immunology
51 publications, 1.95%
|
|
|
Journal of Virology
37 publications, 1.42%
|
|
|
Journal of Medical Virology
35 publications, 1.34%
|
|
|
Scientific Reports
34 publications, 1.3%
|
|
|
Nature Communications
32 publications, 1.22%
|
|
|
Vaccines
29 publications, 1.11%
|
|
|
Frontiers in Cellular and Infection Microbiology
23 publications, 0.88%
|
|
|
mBio
23 publications, 0.88%
|
|
|
Frontiers in Microbiology
21 publications, 0.8%
|
|
|
Molecules
19 publications, 0.73%
|
|
|
International Journal of Biological Macromolecules
19 publications, 0.73%
|
|
|
Microorganisms
18 publications, 0.69%
|
|
|
PLoS Pathogens
18 publications, 0.69%
|
|
|
Nucleic Acids Research
18 publications, 0.69%
|
|
|
Pharmaceuticals
17 publications, 0.65%
|
|
|
Journal of Biomolecular Structure and Dynamics
17 publications, 0.65%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
17 publications, 0.65%
|
|
|
Antiviral Research
16 publications, 0.61%
|
|
|
Cell Reports
16 publications, 0.61%
|
|
|
Journal of Medicinal Chemistry
16 publications, 0.61%
|
|
|
Pathogens
15 publications, 0.57%
|
|
|
Signal Transduction and Targeted Therapy
15 publications, 0.57%
|
|
|
Journal of Biological Chemistry
15 publications, 0.57%
|
|
|
Heliyon
15 publications, 0.57%
|
|
|
Virology Journal
14 publications, 0.54%
|
|
|
iScience
14 publications, 0.54%
|
|
|
10
20
30
40
50
60
70
80
90
100
|
Publishers
|
100
200
300
400
500
600
|
|
|
Elsevier
503 publications, 19.24%
|
|
|
MDPI
388 publications, 14.84%
|
|
|
Springer Nature
348 publications, 13.31%
|
|
|
Cold Spring Harbor Laboratory
328 publications, 12.55%
|
|
|
Frontiers Media S.A.
171 publications, 6.54%
|
|
|
Wiley
143 publications, 5.47%
|
|
|
American Society for Microbiology
89 publications, 3.4%
|
|
|
Taylor & Francis
83 publications, 3.18%
|
|
|
American Chemical Society (ACS)
82 publications, 3.14%
|
|
|
Oxford University Press
46 publications, 1.76%
|
|
|
Public Library of Science (PLoS)
39 publications, 1.49%
|
|
|
Bentham Science Publishers Ltd.
37 publications, 1.42%
|
|
|
Royal Society of Chemistry (RSC)
21 publications, 0.8%
|
|
|
American Association for the Advancement of Science (AAAS)
20 publications, 0.77%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
17 publications, 0.65%
|
|
|
Portland Press
14 publications, 0.54%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
13 publications, 0.5%
|
|
|
eLife Sciences Publications
11 publications, 0.42%
|
|
|
SAGE
9 publications, 0.34%
|
|
|
American Society for Biochemistry and Molecular Biology
9 publications, 0.34%
|
|
|
Microbiology Society
8 publications, 0.31%
|
|
|
Baishideng Publishing Group
8 publications, 0.31%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
8 publications, 0.31%
|
|
|
IntechOpen
8 publications, 0.31%
|
|
|
Rockefeller University Press
7 publications, 0.27%
|
|
|
American Society for Clinical Investigation
5 publications, 0.19%
|
|
|
Spandidos Publications
5 publications, 0.19%
|
|
|
Hindawi Limited
5 publications, 0.19%
|
|
|
Annual Reviews
5 publications, 0.19%
|
|
|
100
200
300
400
500
600
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
2.6k
Total citations:
2615
Citations from 2025:
384
(14.69%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
V’kovski P. et al. Coronavirus biology and replication: implications for SARS-CoV-2 // Nature Reviews Microbiology. 2020. Vol. 19. No. 3. pp. 155-170.
GOST all authors (up to 50)
Copy
V’kovski P., Kratzel A., Steiner S., Stalder H., Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2 // Nature Reviews Microbiology. 2020. Vol. 19. No. 3. pp. 155-170.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/s41579-020-00468-6
UR - https://doi.org/10.1038/s41579-020-00468-6
TI - Coronavirus biology and replication: implications for SARS-CoV-2
T2 - Nature Reviews Microbiology
AU - V’kovski, Philip
AU - Kratzel, Annika
AU - Steiner, Silvio
AU - Stalder, Hanspeter
AU - Thiel, V.
PY - 2020
DA - 2020/10/28
PB - Springer Nature
SP - 155-170
IS - 3
VL - 19
PMID - 33116300
SN - 1740-1526
SN - 1740-1534
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_V’kovski,
author = {Philip V’kovski and Annika Kratzel and Silvio Steiner and Hanspeter Stalder and V. Thiel},
title = {Coronavirus biology and replication: implications for SARS-CoV-2},
journal = {Nature Reviews Microbiology},
year = {2020},
volume = {19},
publisher = {Springer Nature},
month = {oct},
url = {https://doi.org/10.1038/s41579-020-00468-6},
number = {3},
pages = {155--170},
doi = {10.1038/s41579-020-00468-6}
}
Cite this
MLA
Copy
V’kovski, Philip, et al. “Coronavirus biology and replication: implications for SARS-CoV-2.” Nature Reviews Microbiology, vol. 19, no. 3, Oct. 2020, pp. 155-170. https://doi.org/10.1038/s41579-020-00468-6.